{"id":"pancrelipase-capsules","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Hyperuricemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Pancrelipase contains lipase, protease, and amylase derived from porcine pancreatic tissue. These enzymes are essential for breaking down dietary macronutrients in the small intestine. In patients with pancreatic insufficiency, endogenous enzyme production is inadequate, leading to malabsorption; pancrelipase supplementation restores digestive capacity and nutrient absorption.","oneSentence":"Pancrelipase is a mixture of pancreatic enzymes (lipase, protease, and amylase) that replaces deficient endogenous pancreatic enzymes to restore normal digestion of fats, proteins, and carbohydrates.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:35:40.150Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pancreatic exocrine insufficiency due to chronic pancreatitis"},{"name":"Pancreatic exocrine insufficiency due to cystic fibrosis"},{"name":"Pancreatic exocrine insufficiency due to pancreatic surgery or obstruction"}]},"trialDetails":[{"nctId":"NCT04098237","phase":"PHASE2","title":"Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Andrew Hendifar, MD","startDate":"2020-12-17","conditions":"Pancreatic Adenocarcinoma","enrollment":36},{"nctId":"NCT07335523","phase":"PHASE2","title":"Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Digestive Care, Inc.","startDate":"2026-03","conditions":"Steatorrhea","enrollment":30},{"nctId":"NCT07314489","phase":"EARLY_PHASE1","title":"A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2025-04-01","conditions":"Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose","enrollment":80},{"nctId":"NCT06477159","phase":"PHASE4","title":"Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-02-01","conditions":"Exocrine Pancreatic Insufficiency","enrollment":60},{"nctId":"NCT06826105","phase":"NA","title":"Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)","status":"RECRUITING","sponsor":"Philipp Schuetz","startDate":"2025-09-22","conditions":"Malnutrition","enrollment":20},{"nctId":"NCT07074379","phase":"NA","title":"Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-21","conditions":"Painless Chronic Pancreatitis","enrollment":126},{"nctId":"NCT06099119","phase":"PHASE4","title":"Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.","status":"RECRUITING","sponsor":"Hospital Clinico Universitario de Santiago","startDate":"2024-02-20","conditions":"Unresectable Pancreatic Cancer","enrollment":100},{"nctId":"NCT05266963","phase":"EARLY_PHASE1","title":"Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-09-02","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT05069597","phase":"PHASE4","title":"Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon","status":"COMPLETED","sponsor":"AbbVie","startDate":"2021-10-14","conditions":"Cystic Fibrosis, Chronic Pancreatitis","enrollment":30},{"nctId":"NCT04949828","phase":"","title":"Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms","status":"COMPLETED","sponsor":"AbbVie","startDate":"2021-09-16","conditions":"Chronic Pancreatitis","enrollment":63},{"nctId":"NCT06119880","phase":"PHASE4","title":"The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2023-11-01","conditions":"Pancreatic Exocrine Insufficiency, Pancreatic Enzyme Replacement Therapy, Pancreaticoduodenectomy","enrollment":100},{"nctId":"NCT03924947","phase":"PHASE4","title":"A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-10-23","conditions":"Cystic Fibrosis","enrollment":36},{"nctId":"NCT03859869","phase":"PHASE4","title":"A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)","status":"TERMINATED","sponsor":"AbbVie","startDate":"2020-02-25","conditions":"Exocrine Pancreatic Insufficiency (EPI)","enrollment":1},{"nctId":"NCT05261997","phase":"NA","title":"Endotherapy for Painless Chronic Pancreatitis","status":"UNKNOWN","sponsor":"Changhai Hospital","startDate":"2022-03","conditions":"Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain","enrollment":60},{"nctId":"NCT03757455","phase":"NA","title":"ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy","status":"TERMINATED","sponsor":"Tampere University Hospital","startDate":"2020-09-01","conditions":"Pancreatic Cancer, Surgery--Complications, Pancreatic Fistula","enrollment":35},{"nctId":"NCT03450772","phase":"PHASE3","title":"Equivalence Study to Compare Two Strengths of Creon in China","status":"UNKNOWN","sponsor":"Abbott","startDate":"2017-08-31","conditions":"Pancreatic Insufficiency","enrollment":60},{"nctId":"NCT04315311","phase":"PHASE4","title":"Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer","status":"WITHDRAWN","sponsor":"AbbVie","startDate":"2020-05-06","conditions":"Exocrine Pancreatic Insufficiency (EPI)","enrollment":""},{"nctId":"NCT02985801","phase":"PHASE1, PHASE2","title":"PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer","status":"TERMINATED","sponsor":"Massimo Raimondo, M.D.","startDate":"2016-12","conditions":"Pancreatic Insufficiency, Pancreatic Cancer, Pancreatic Enzyme Abnormality","enrollment":16},{"nctId":"NCT02097394","phase":"PHASE4","title":"The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2013-06","conditions":"Combizym, Bifidobacteri, Colon Polyps","enrollment":200},{"nctId":"NCT01159119","phase":"PHASE1","title":"A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain","status":"TERMINATED","sponsor":"Forest Laboratories","startDate":"2010-08-02","conditions":"Chronic Pancreatitis","enrollment":15},{"nctId":"NCT01865695","phase":"PHASE4","title":"Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase","status":"TERMINATED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2013-05","conditions":"Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks), Patients With Pancreatic Exocrine Insufficiency","enrollment":2},{"nctId":"NCT02849704","phase":"PHASE2","title":"Fat Malabsorption in Chronic Pancreatitis","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2016-10-13","conditions":"Chronic Pancreatitis","enrollment":48},{"nctId":"NCT01641341","phase":"PHASE4","title":"Irritable Bowel Syndrome Evaluation and Treatment in Primary Care","status":"COMPLETED","sponsor":"American Academy of Family Physicians","startDate":"2010-11","conditions":"Irritable Bowel Syndrome","enrollment":61},{"nctId":"NCT01131507","phase":"PHASE4","title":"PR-018: An Open-Label, Safety Extension of Study PR-011","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2010-07","conditions":"Cystic Fibrosis, Exocrine Pancreatic Insufficiency","enrollment":15},{"nctId":"NCT00981214","phase":"PHASE3","title":"Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2006-05","conditions":"Cystic Fibrosis, Exocrine Pancreatic Insufficiency","enrollment":19},{"nctId":"NCT00880100","phase":"PHASE3","title":"Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2009-04","conditions":"Cystic Fibrosis, Pancreatic Insufficiency","enrollment":49},{"nctId":"NCT00513682","phase":"PHASE3","title":"Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-07","conditions":"Cystic Fibrosis, Pancreatic Insufficiency","enrollment":9},{"nctId":"NCT00408317","phase":"PHASE3","title":"Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2006-11","conditions":"Cystic Fibrosis, Exocrine Pancreatic Insufficiency","enrollment":36},{"nctId":"NCT02137382","phase":"PHASE3","title":"A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-01","conditions":"Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis","enrollment":41},{"nctId":"NCT01430234","phase":"PHASE4","title":"Enzyme Suppletion in Exocrine Pancreatic Dysfunction","status":"COMPLETED","sponsor":"Foundation for Liver Research","startDate":"2011-10","conditions":"Chronic Pancreatitis, Exocrine Pancreatic Insufficiency","enrollment":10},{"nctId":"NCT02009410","phase":"PHASE4","title":"A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2","status":"WITHDRAWN","sponsor":"Abbott","startDate":"2013-11","conditions":"Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2","enrollment":""},{"nctId":"NCT00662675","phase":"PHASE3","title":"A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-08","conditions":"Exocrine Pancreatic Insufficiency, Steatorrhea, Malabsorption Syndromes","enrollment":40},{"nctId":"NCT01327703","phase":"PHASE4","title":"Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2011-04","conditions":"Exocrine Pancreatic Insufficiency, Cystic Fibrosis","enrollment":87},{"nctId":"NCT01100606","phase":"PHASE4","title":"A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2010-06","conditions":"Cystic Fibrosis, Exocrine Pancreatic Insufficiency","enrollment":15},{"nctId":"NCT01641393","phase":"PHASE3","title":"Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-06","conditions":"Exocrine Pancreatic Insufficiency: Cystic Fibrosis","enrollment":96},{"nctId":"NCT00788593","phase":"PHASE3","title":"A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-01","conditions":"Chronic Pancreatitis, Exocrine Pancreatic Insufficiency","enrollment":82},{"nctId":"NCT00744250","phase":"PHASE4","title":"Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control","status":"TERMINATED","sponsor":"Digestive Care, Inc.","startDate":"2008-08","conditions":"Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Cystic Fibrosis","enrollment":3},{"nctId":"NCT00749099","phase":"NA","title":"Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)","status":"TERMINATED","sponsor":"Digestive Care, Inc.","startDate":"2007-04","conditions":"Exocrine Pancreatic Insufficiency","enrollment":11},{"nctId":"NCT01142128","phase":"PHASE1","title":"Viokase 16, Viokase16 Plus Nexium and Nexium Alone","status":"TERMINATED","sponsor":"University of Florida","startDate":"2009-02","conditions":"Chronic Pancreatitis","enrollment":12},{"nctId":"NCT01114113","phase":"NA","title":"Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal","status":"WITHDRAWN","sponsor":"Money, Mary E., M.D.","startDate":"2010-04","conditions":"Irritable Bowel Syndrome, Diarrhea","enrollment":""},{"nctId":"NCT00432861","phase":"PHASE3","title":"Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis","status":"COMPLETED","sponsor":"Digestive Care, Inc.","startDate":"2007-01","conditions":"Cystic Fibrosis, Pancreatic Insufficiency","enrollment":29},{"nctId":"NCT00535756","phase":"PHASE4","title":"Creon After Pancreatic Surgery","status":"COMPLETED","sponsor":"Abbott Products","startDate":"2008-04","conditions":"Pancreatic Insufficiency","enrollment":58},{"nctId":"NCT00705978","phase":"PHASE3","title":"Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis","status":"COMPLETED","sponsor":"Abbott Products","startDate":"2008-06","conditions":"Pancreatic Insufficiency","enrollment":62},{"nctId":"NCT00414908","phase":"PHASE3","title":"A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2007-10","conditions":"Chronic Pancreatitis, Pancreatectomy, Pancreatic Exocrine Insufficiency","enrollment":52},{"nctId":"NCT00623025","phase":"PHASE3","title":"Creon in HIV Patients With Steatorrhea","status":"TERMINATED","sponsor":"Abbott","startDate":"2009-01","conditions":"Steatorrhea","enrollment":34},{"nctId":"NCT00676702","phase":"PHASE1","title":"A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-07","conditions":"Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic, Steatorrhea","enrollment":13},{"nctId":"NCT00775528","phase":"PHASE3","title":"Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2009-04","conditions":"Cystic Fibrosis, Pancreatic Exocrine Insufficiency","enrollment":19},{"nctId":"NCT00510484","phase":"PHASE3","title":"Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2007-11","conditions":"Cystic Fibrosis","enrollment":35},{"nctId":"NCT00690820","phase":"PHASE3","title":"Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2008-06","conditions":"Cystic Fibrosis, Pancreatic Exocrine Insufficiency","enrollment":17},{"nctId":"NCT00663975","phase":"NA","title":"Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients","status":"WITHDRAWN","sponsor":"Digestive Care, Inc.","startDate":"2009-02","conditions":"Digestive System Diseases, Pancreatic Disease, Cystic Fibrosis","enrollment":24},{"nctId":"NCT00160186","phase":"PHASE4","title":"Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2003-12","conditions":"Gastrectomy","enrollment":40},{"nctId":"NCT00006063","phase":"NA","title":"Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"1999-07","conditions":"Cystic Fibrosis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"ATRIAL FIBRILLATION"},{"count":1,"reaction":"ARTERIOSCLEROSIS"},{"count":1,"reaction":"CELLULITIS"},{"count":1,"reaction":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"count":1,"reaction":"COLITIS ISCHAEMIC"},{"count":1,"reaction":"DIABETES MELLITUS"},{"count":1,"reaction":"DUODENITIS"},{"count":1,"reaction":"EXPOSURE DURING PREGNANCY"},{"count":1,"reaction":"HYPERGLYCAEMIA"},{"count":1,"reaction":"HYPONATRAEMIA"}],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CREON"],"phase":"marketed","status":"active","brandName":"Pancrelipase Capsules","genericName":"Pancrelipase Capsules","companyName":"Ohio State University","companyId":"ohio-state-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pancrelipase is a mixture of pancreatic enzymes (lipase, protease, and amylase) that replaces deficient endogenous pancreatic enzymes to restore normal digestion of fats, proteins, and carbohydrates. Used for Pancreatic exocrine insufficiency due to chronic pancreatitis, Pancreatic exocrine insufficiency due to cystic fibrosis, Pancreatic exocrine insufficiency due to pancreatic surgery or obstruction.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2009-04-30T00:00:00.000Z","mah":"ABBVIE","brand_name_local":"CREON","application_number":"BLA020725"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}